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ABSTRACT Infection with Brachyspira hyodysenteriae results in mucoid hemorrhagic
diarrhea. This pathogen is associated with the colonic mucus layer, mainly com-
posed of mucins. Infection regulates mucin O-glycosylation in the colon and in-
creases mucin secretion as well as B. hyodysenteriae binding sites on mucins. Here,
we analyzed potential mucin epitopes for B. hyodysenteriae adhesion in the colon, as
well as the effect of colonic mucins on bacterial growth. Associations between B.
hyodysenteriae binding to pig colonic mucins and mucin glycan data showed that B.
hyodysenteriae binding was associated with the presence of N-glycolylneuraminic
acid (NeuGc) on mucins. The role of sialic acid in B. hyodysenteriae adhesion was ana-
lyzed after the removal of sialic acid residues on the mucins by enzymatic treatment
with sialidase A, which decreased bacterial binding to the mucins. The effect of pig co-
lonic mucins on B. hyodysenteriae growth was determined in carbohydrate-free medium.
B. hyodysenteriae growth increased in the presence of mucins from two out of ﬁve in-
fected pigs, suggesting utilization of mucins as a carbon source for growth. Additionally,
bacterial growth was enhanced by free sialic acid and N-acetylglucosamine. The results
highlight a role of sialic acid as an adhesion epitope for B. hyodysenteriae interaction
with colonic mucins. Furthermore, the mucin response and glycosylation changes ex-
erted in the colon during B. hyodysenteriae infection result in a potentially favorable en-
vironment for pathogen growth in the intestinal mucus layer.
KEYWORDS Brachyspira hyodysenteriae, adhesion, colon, mucins, pig, sialic acid
The mucosal surface lining the gastrointestinal tract is covered by a mucus layer thatprotects the epithelial surface and acts as a barrier against pathogens (1). This
mucus layer is mainly composed of heavily glycosylated gel-forming mucins secreted
by goblet cells (1). Similar to the colonic mucus layer in mice and humans, the colonic
mucus layer in healthy pigs is organized in striations parallel to the mucosal surface and
is mainly composed of MUC2 mucin (2–5). Mucins carry an array of carbohydrate
structures that vary between species and individuals, in tissue distribution, and in
response to bacterial infection (1, 6–13). The mucin glycan structures are also available
for host-pathogen interactions, such as bacterial attachment via adhesins, limiting
colonization and access to the epithelial surface (14–18). Mucin glycosylation changes
due to bacterial infections can affect pathogen attachment (19–23). Furthermore, pig
intestinal bacteria can degrade mucins and utilize mucin carbohydrates as an energy
source for growth (13, 24–26).
Brachyspira hyodysenteriae is a causative agent associated with swine dysentery
(SD), a disease characterized by mucohemorrhagic colitis. SD results in decreased
performance parameters, such as reduced feed conversion and weight gain, ac-
companied by 30% mortality and 90% morbidity in weaned pigs (27, 28). The
emergence of antimicrobial-resistant B. hyodysenteriae strains (29–32) suggests the
need for alternative strategies to treat infections. Colonization of the colon with
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the pathogen B. hyodysenteriae profoundly alters the mucus layer organization and
mucin composition in the colon with the loss of the striated mucus organization
and aberrant mucin production, characterized by the increased expression of MUC2
and the de novo expression of MUC5AC (2, 33). This mucin increase is accompanied
by an increase in the ability of B. hyodysenteriae to bind to mucins (2). The host’s
colonic mucosal immune response to B. hyodysenteriae infection is involved in the
regulatory networks determining mucin expression. Neutrophil elastase and interleukin-17
(IL-17), part of the colonic mucosal immune response to B. hyodysenteriae infection, induce
mucin production synergistically with B. hyodysenteriae via mitogen-activated protein
kinase 3 (34). B. hyodysenteriae infection regulates mucin glycosylation synthesis in the
colon, resulting in the loss of interindividual variation, shorter glycan chains, and a higher
abundance of neutral, core 2, and N-glycolylneuraminic acid (NeuGc)- and sulfate-
containing structures compared to healthy pigs (8).
B. hyodysenteriae infection increases the bacterial binding sites on mucins, and
since binding differs between pigs, it is highly likely that binding occurs via the
mucin glycans (2). However, the glycan residues that B. hyodysenteriae interacts
with in the colon remain unknown. We recently characterized the mucin O-glycome
in the colon of B. hyodysenteriae-infected and healthy pigs, providing a database of
glycan structures, some of which could be relevant for host-pathogen interactions
(8). Therefore, the overall aims of the present study were to identify potential mucin
glycan epitopes involved in B. hyodysenteriae binding to colonic mucins, as well as
the effect of mucins and their composition on bacterial growth. The results high-
light a role of sialic acid as an adhesion epitope for B. hyodysenteriae interaction
with colonic mucins. Furthermore, B. hyodysenteriae can utilize mucins from in-
fected pigs, sialic acid, and N-acetylglucosamine (GlcNAc) as energy sources.
RESULTS AND DISCUSSION
B. hyodysenteriae binding to pig colonic mucins is associated with the presence
of NeuGc on mucins. We have previously shown that B. hyodysenteriae adheres to
colonic mucins in a manner that differs between pigs (2) and that bacterial infection
results in changes of the mucin glycan proﬁle in the colon (8). Although these data have
been presented before, they have not been previously intercorrelated. Associations
between the previously reported B. hyodysenteriae binding to colonic mucins from
infected and healthy pig data (2) and pig mucin O-glycome data (8) were determined
to identify potential epitopes involved in B. hyodysenteriae adhesion to colonic mucins.
Mass spectrometry data for the 94 mucin O-glycan structures, as well as groups of
structures with similar features (i.e., acidic, neutral, sulfated, sialylated, core type 1, 2, 3,
or 4, blood group H or A, Lewis type a/x or b/y, terminal galactose, and NeuGc or
NeuAc) were considered in the correlation analysis. More than 80% of the pig colonic
mucins from both B. hyodysenteriae-infected and healthy pigs are insoluble in guani-
dinium hydrochloride (GuHCl), and bacterial binding to these was higher than to
mucins soluble in GuHCl (2). Overall, there was a statistically signiﬁcant correlation
between B. hyodysenteriae adhesion to GuHCl-insoluble mucins and the abundance of
sialic acid-containing structures on pig colonic mucins (Table 1; r 0.80, P 0.02). The
association between bacterial binding and the presence of sialylated structures on
mucins was mainly given by the NeuGc residue (Table 1; r 0.72, P 0.04), as there
was no statistically signiﬁcant association between the amount of NeuAc-based struc-
tures alone and B. hyodysenteriae binding to mucins (r 0.39, P 0.36). Thus, an
increased B. hyodysenteriae binding ability was associated with a higher abundance of
NeuGc on mucins. These results are in line with the higher abundance of NeuGc
detected on B. hyodysenteriae-infected pig mucins and the equal proportion of NeuGc
and NeuAc detected in healthy pigs (8), paralleling the higher binding to B.
hyodysenteriae-infected pig mucins than to noninfected pig mucins (2). Overall, this
indicates a potential interaction between B. hyodysenteriae and NeuGc residues on
mucins. Additionally, associations were observed between B. hyodysenteriae binding
and mucin glycan chains mainly containing NeuGc or terminal galactose with a (1-3)
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linkage, out of which Gal-GlcNAc-Gal1,3(GalNAc1,4(Sul)GlcNAc1,6)GalNAcol and
GlcNAc1,3/4Gal1,3(Fuc-Gal1,3/4(Fuc)GlcNAc1,3/4Gal1,3/4GlcNAc1,6)GalNAcol
were unique to mucins from B. hyodysenteriae-infected pigs (Table 1).
Removal of sialic acid residues decreases B. hyodysenteriae adhesion to pig
colonic mucins. The ﬁndings of an association between B. hyodysenteriae adhesion and
mucin glycan chains carrying NeuGc or terminal galactose led us to study the potential
role of sialic acid and galactose residues in B. hyodysenteriae adhesion. Bacterial binding
was analyzed after sialidase A and -galactosidase enzymatic treatment of the insoluble
mucins. Sialidase A cleaves both NeuGc and NeuAc structures from complex carbohy-
drates, while -galactosidase hydrolyzes nonreducing terminal galactose (1-3) and
(1-4) linkages. In line with the statistical correlation between B. hyodysenteriae binding
and the relative abundance of sialic acids, we observed that B. hyodysenteriae’s ability
to bind to insoluble mucins decreased after sialidase A treatment compared to that for
the non-enzyme-treated mucin control (P 0.0001; Fig. 1). In contrast, adhesion to
TABLE 1 Associations between B. hyodysenteriae binding to pig mucins and mucin O-glycan data from B. hyodysenteriae-infected and
healthy pigsa
Mucin r P value CI
Insoluble mucinsb
Sialic acids (NeuAc  NeuGc) 0.80 0.02 0.22–0.96
NeuGc 0.72 0.04 0.03–0.94
Gal1,3(NeuGc2,6)GalNAcol 0.73 0.04 0.04–0.94
Gal1,3(NeuAc-GlcNAc1,6)GalNAcol 0.76 0.03 0.11–0.95
NeuGc-Gal1,3(Gal1,3/4(Fuc)GlcNAc1,6)GalNAcol 0.82 0.01 0.28–0.97
NeuGc-Gal1,3(GlcNAc-Gal1,4(Sul)GlcNAc1,6)GalNAcol 0.71 0.05 0.005–0.94
Gal-GlcNAc-Gal1,3(GalNAc1,4(Sul)GlcNAc1,6)GalNAcol 0.75 0.03 0.09–0.95
Soluble mucins
NeuGc-Gal1,3(Fuc-Gal1,3/4(Fuc)GlcNAc1,6)GalNAcol 0.7 0.02 0.17–0.93
GlcNAc1,3/4Gal1,3(Fuc-Gal1,3/4(Fuc)GlcNAc1,3/4Gal1,3/4GlcNAc1,6)GalNAcol 0.8 0.00 0.36–0.95
NeuGc2,3Gal1,3(GalNAc1,4(Sul)GlcNAc1,4)Gal1,3(Fuc1,2Gal(Fuc)GlcNAc1,6)GalNAcol 0.6 0.05 0.004–0.90
aData for associations between B. hyodysenteriae binding to pig mucins are from reference 2, and mucin O-glycan data from B. hyodysenteriae-infected and healthy
pigs are from reference 8. r, Pearson product-moment correlation coefﬁcient determining the relationship between binding to mucins and mucin glycan data from B.
hyodysenteriae-infected (n 5) and healthy (n 5) pigs; CI, conﬁdence interval; Gal, galactose; GalNAc, N-acetylgalactosamine; NeuAc, N-acetylneuraminic acid; Fuc,
fucose; Sul, sulfate; GlucNAc, N-acetylglucosamine.
bMucins insoluble in GuHCl were solubilized by reduction and alkylation, breaking the disulﬁde bonds that link the mucin monomers into large complexes.
FIG 1 B. hyodysenteriae adhesion to enzyme-treated mucins. The binding of B. hyodysenteriae to sialidase
A- and (1-4)-galactosidase-treated pig colonic mucins compared to mock (non-enzyme)-treated mucins
is shown. The results are expressed as the mean  SEM for technical replicates from three independent
experiments. P values were determined by one-way ANOVA with Dunnett’s correction for multiple
comparisons. ****, P 0.0001.
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-galactosidase-treated mucins remained unchanged (P 0.05; Fig. 1). These ﬁndings
infer that B. hyodysenteriae binds to sialic acid-containing structures on mucins, as the
removal of sialic acid hampered adhesion to mucins. An afﬁnity for sialic acid epitopes
on intestinal pig mucins has also been demonstrated in Escherichia coli K99 (35). It is
possible that the sialic acids present on mucins play a role in B. hyodysenteriae
colonization of the intestinal mucosa, as adhesion of a gastric pathogen to mucins can
limit access to the epithelial surface: mice lacking the Muc1 mucin are more susceptible
to infection by Helicobacter pylori and MUC1 acts as a releasable decoy for H. pylori
binding to the gastric epithelial surface (15, 18). Furthermore, H. pylori-infected children
and rhesus monkeys secreting mucins with less H. pylori binding capacity develop
higher-density H. pylori infections and gastritis (9, 19). Together, these results support
the suggestion that the ability of mucins to bind H. pylori protects the gastric epithe-
lium. It is likely that these types of mechanisms are also relevant as protection against
B. hyodysenteriae colonization; however, during infection the mucus layer is so disor-
ganized (2) that these protection mechanisms may be impaired.
Functional analysis of B. hyodysenteriae sialidase activity. Several mucosal
pathogens and commensal bacteria carry sialidases, also known as neuraminidases,
that can hydrolyze the glycosidic linkages of the terminal sialic acid residue in oligo-
saccharides and glycoproteins (36, 37). The sequenced B. hyodysenteriae BHWA1 strain
carries a predicted/hypothetical sialidase gene coding for the sialidase protein (38);
however, there are no functional studies conﬁrming its sialidase activity or sialidase
protein expression. For this purpose, B. hyodysenteriae was incubated with the 2=-(4-
methylumbelliferyl)--D-N-acetylneuraminic acid sodium salt hydrate substrate, unex-
pectedly showing no difference in the luminescent signal from that with the substrate
alone (P 0.05; Fig. 2). Thus, B. hyodysenteriae was unable to cleave the ﬂuorescent
NeuAc substrate, as demonstrated by a luminescent signal signiﬁcantly lower than that
for the substrate and sialidase A-positive control (P 0.0001; Fig. 2), overall suggesting
that the ability of B. hyodysenteriae to cleave sialic acid on mucins is limited.
Colonic mucins from infected pigs enhance B. hyodysenteriae growth. As we
previously reported, B. hyodysenteriae infection regulates mucin glycosylation in the
colon (8); however, it is unknown whether the resulting changes have a stimulatory,
inhibitory, or no effect on pathogen growth. The effect of pig colonic mucins on B.
hyodysenteriae growth was determined in carbohydrate-free medium in coculture with
FIG 2 Functional analysis of B. hyodysenteriae (B. hyo) sialidase activity. The neuraminidase activity of B.
hyodysenteriae was measured as the number of relative ﬂuorescence units (RFU) after 10 h of incubation
with a 4-methylumbelliferyl-N-acetyl--D-neuraminic acid sodium salt hydrate substrate. Medium and
substrate were used as a negative control, while sialidase A and substrate were used as a positive control.
Results are expressed as the mean  SEM for technical replicates from two independent experiments. P
values were determined by one-way ANOVA with Tukey’s correction for multiple comparisons. ****,
P 0.0001.
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dialyzed mucins from healthy (n 6) and B. hyodysenteriae-infected (n 5) pig colon.
Growth was measured as a luminescent signal that is dependent on the reduction of
the cell viability assay substrate by viable cells and rapid turnover by NanoLuc lu-
ciferase. The resulting luminescent signal is proportional to the number of B. hyodysen-
teriae live cells in culture. B. hyodysenteriae growth increased in the presence of mucins
from two out of ﬁve infected pigs compared to the nonmucin control (pig 3, P 0.01;
pig 4, P 0.001; Fig. 3). Mucins from pigs 3 and 4 moderately increased B. hyodysen-
teriae growth by 6.7% and 8.2% respectively (Fig. 3). Pigs 3 and 4 had an earlier onset
of SD (clinical signs started at 12 to 15 days postinfection) and a longer duration of
clinical signs (25 to 28 days) than pigs 1, 2, and 5 (clinical signs started at 29 to 39 days
postinfection and lasted for 1 to 11 days) (2). In contrast, colonic mucins from healthy
pigs did not have a growth-enhancing effect compared to phosphate-buffered saline
(PBS) (Fig. 3). No statistically signiﬁcant differences in overall proliferation means
were observed between the PBS, control pig mucin, and infected pig mucin groups
(P 0.05).
B. hyodysenteriae growth correlated with the presence of overall sialic acid (r 0.7,
P 0.03), NeuAc/Gc with an 2,3-galactose linkage (r 0.7, P 0.01), and terminal
galactose (r 0.8, P 0.002). The results suggest that B. hyodysenteriae utilizes mucins
as a nutrient source, consistent with data from other pig intestinal bacterial species that
can degrade mucins and use their components for growth (25, 26). It is possible that
the host’s altered mucin environment in response to B. hyodysenteriae infection is
advantageous for the pathogen, modulating its growth.
B. hyodysenteriae growth increases in the presence of free sialic acid and
N-acetylglucosamine. To investigate the mucin epitopes that could contribute to the
growth-enhancing effect of mucins on B. hyodysenteriae, bacteria were cultured in the
presence of galactose, fucose, NeuAc, NeuGc, GalNAc, and GlcNAc, monosaccharides
that are present as terminal residues on mucins. Among the studied carbohydrates, the
NeuGc and NeuAc sialic acids had a surprisingly stimulatory effect on B. hyodysenteriae,
increasing its growth by 105.3% and 107.9%, respectively, in comparison to that of the
no-carbohydrate control (P 0.0001 for all; Fig. 4). In line with our results, intestinal
sialic acid catabolism has been demonstrated to be advantageous for pathogens like
FIG 3 Effect of pig colonic mucins on B. hyodysenteriae growth. B. hyodysenteriae growth was determined
in carbohydrate-free medium in coculture with dialyzed colon-insoluble mucins from healthy pigs (pigs
A to F, n 6) and B. hyodysenteriae-infected pigs (pigs 1 to 5, n 5) and compared to the growth of the
non-mucin-treated control (PBS). Results are expressed as the mean  SEM for technical replicates from
two independent experiments. P values were determined by one-way ANOVA with Dunnett’s correction
for multiple comparisons. *, P 0.05; ***, P 0.001.
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Vibrio cholerae, which can degrade and grow on sialic acid (39). In line with the
growth-enhancing effects of GlcNAc on Aeromonas salmonicida (40), GlcNAc increased
B. hyodysenteriae growth by 78.9% compared to that of the no-carbohydrate control
(P 0.0001; Fig. 4). The role of GlcNAc in the synthesis of the bacterial cell wall
peptidoglycan may possibly contribute to the growth-promoting effects of GlcNAc.
Similarly, the intestinal mucosa-associated commensal bacterium Cloacibacillus porco-
rum has mucolytic activity and can grow on mucin and its components, including
NeuAc and GlcNAc (26).
Although B. hyodysenteriae was not capable of cleaving NeuAc in vitro, we cannot
rule out the potential cleavage of NeuGc on mucins. There is evidence of interplay
between B. hyodysenteriae and other members of the microbiota during SD, as the
presence of other anaerobes, along with B. hyodysenteriae, is required for the devel-
opment of SD (41). Furthermore, a higher relative abundance of Campylobacter, Fuso-
bacterium, and Mogibacterium was found in mucosal scrapings and luminal samples
from pigs with SD compared to pigs without the disease (42). It is possible that B.
hyodysenteriae can scavenge free sialic acid cleaved by commensal bacteria, such as
Clostridium and Bacteroides species (43, 44), from the surrounding environment or the
host pig’s intestinal mucosa (42). Thus, the ability to use the free sialic acids and GlcNAc
present on the mucosal surface of the pig colon as energy and carbon sources could
be beneﬁcial for B. hyodysenteriae’s survival in the colon.
Several factors, including infections, diet, weaning, and age, can affect pig intestinal
glycosylation (8, 45, 46). Differences in the NeuAc2,6 versus NeuAc2,3 content of the
pig small intestine have been reported at birth and at weaning (47), and experimental
infection of conventional versus speciﬁc-pathogen-free pigs with Trichinella spiralis
results in differential sulfation and sialylation patterns (48), suggesting that numerous
circumstances can lead to glycosylation changes that in turn have the potential to
affect pathogen interactions with its host. B. hyodysenteriae infection results in a higher
abundance of NeuGc-containing structures, compared to the equal distribution of
NeuGc- and NeuAc-containing structures in healthy pigs (8). Furthermore, expression of
sulfated mucins is decreased in the colon of B. hyodysenteriae-infected pigs (8, 33). This
opens up the question as to whether the loss of sulfated residues exposes sialic acids
for B. hyodysenteriae binding. However, sulfate moieties in the vicinity of sialic acids
were rare: we identiﬁed only ﬁve sulfated glycan structures that carried sialic
FIG 4 B. hyodysenteriae growth in the presence of monosaccharides. Bacterial growth was determined in
deﬁned medium (without glucose) in coculture with carbohydrates and compared to that in the
non-carbohydrate-treated control (PBS). Results are expressed as the mean  SEM from three indepen-
dent experiments. P values were determined by one-way ANOVA with Dunnett’s correction for multiple
comparisons. ****, P 0.0001.
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acids, including NeuAc and NeuGc (Table 2). In contrast to the decrease in overall
sulfation among mucins from infected pigs, the abundance of sulfated glycan struc-
tures that carry sialic acids tended to be higher among mucins from infected pigs (4.1%
and 6.8% for soluble and insoluble mucins, respectively) than among mucins from
uninfected pigs (1.9% and 4.1% for soluble and insoluble mucins, respectively)
(P 0.11). As a common theme among these glycans, the sulfation was present on the
branch opposite that of the sialylation. Therefore, exposure of sialic acids due to
decreased sulfation is unlikely to be the cause of the increased sialic acid-dependent B.
hyodysenteriae binding to colonic mucins from infected pigs. However, sulfated glycans
could potentially inhibit bacterial neuraminidases via intermolecular ionic interactions
(49), suggesting that the decrease in overall sulfation among infected pigs may
contribute to making mucin glycans more available as a microbial nutrient.
Conclusion. Here, we provided insights into the interactions of B. hyodysenteriae
with pig intestinal mucin glycans, highlighting the relevance of NeuGc as an adhesion
epitope for bacterial binding to mucins. We identiﬁed that sialic acids are key players
in the interactions between B. hyodysenteriae and host mucins: B. hyodysenteriae
binding to pig colonic mucins occurs in a sialic acid-dependent manner, and both
GlcNAc and sialic acids enhance B. hyodysenteriae growth. The fact that B. hyodysente-
TABLE 2 Sulfated sialoglycans in pigs with and without SD
Structurea
Soluble mucinsb Insoluble mucins
Mean %  SEM
P value
Mean %  SEM
P valueControl Infected Control Infected
— 2.1 1.2 — 0.6 0.2 1.9 0.6 0.06
0.9 0.4 0.3 0.3 0.25 0.5 0.3 1.4 0.5 0.28
0.3 0.3 1.8 0.8 0.14 1.0 0.4 0.5 0.2 0.28
0.7 0.3 — — 1.5 0.4 2.4 0.7 0.56
— — — 0.5 0.2 0.7 0.1 0.70
aYellow squares, GalNAc; purple diamonds, N-acetylneuraminic acid; gray diamonds, N-glycolylneuraminic
acid; red triangles, fucose; blue squares, GlcNAc.
b—, structure absent.
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riae grew only in the presence of mucins from pigs with prolonged clinical signs of SD
suggests a potential time-dependent component change in the mucus composition.
Additionally, infected pig mucins carried a larger array of glycan structures, indicating
that B. hyodysenteriae can adapt to the glycan-rich environment in the mucus layer
during infection. Earlier studies have shown that infection cannot be established in
gnotobiotic pigs after inoculation with pure cultures of B. hyodysenteriae (41, 50). Thus,
in order to develop clinical signs of swine dysentery, B. hyodysenteriae requires the
presence of other anaerobic enteric bacteria in the mucus layer, such as Bacteroides
vulgatus and Fusobacterium necrophorum (41). It is possible that B. hyodysenteriae
beneﬁts from the free sialic acids cleaved by sialidase-producing commensal bacteria in
the colonic mucus layer. Overall, the mucin response and glycosylation changes
exerted in the colon during SD potentially result in a favorable environment for
pathogen growth in the mucus layer.
MATERIALS AND METHODS
Ethics statement. The animal experiments were approved by the ethical committee of the Faculty
of Veterinary Medicine, Ghent University (EC2012/01 and EC2013/147), and complied with all ethical and
husbandry regulations.
Isolation and puriﬁcation of pig colonic mucins. For a detailed description of the experimental
inoculation of pigs and sample collection procedures, refer to the work of Quintana-Hayashi et al. (2).
Brieﬂy, a total of ﬁve 6-week-old pigs (Danish Large White  Piétrain) developed swine dysentery after
oral inoculation with brain heart infusion broth (BHI) containing 108 CFU of B. hyodysenteriae strain 8dII,
while control pigs received sterile BHI. Pigs were fed a commercial starter feed twice per day and had ad
libitum access to water. The pigs were sacriﬁced at 40 days after inoculation. Midsection samples of the
spiral colon of the ﬁve infected pigs and healthy controls were collected for mucin isolation. Fecal
material was removed, and the tissues were rinsed with phosphate-buffered saline (PBS) containing a
protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany), followed by snap-freezing and
storage at 80°C. The isolation of mucin from colon tissue samples was performed by isopycnic density
gradient centrifugation as previously described, obtaining guanidinium hydrochloride (GuHCl)-soluble
and -insoluble mucins (2). Brieﬂy, frozen tissues were drenched with 10 mM sodium phosphate buffer, pH
6.5, containing 0.1 mM phenylmethylsulfonyl ﬂuoride (AppliChem, Darmstadt, Germany). Once thawed,
the mucosal surfaces were scraped with a microscope slide, dispersed with a Dounce homogenizer, and
stirred slowly overnight at 4°C in ice-cold extraction buffer consisting of 6 M GuHCl (AppliChem,
Darmstadt, Germany), 5 mM EDTA (Sigma-Aldrich, St. Louis, MO, USA), 5 mM N-ethylmaleimide (Alfa
Aesar, Karlsruhe, Germany), and 10 mM sodium dihydrogen phosphate at pH 6.5. GuHCl-soluble mucins
were obtained after centrifugation at 23,000 g for 50 min at 4°C, and the remaining material was
reextracted twice by stirring overnight at 4°C in extraction buffer. The remaining pellets contained the
insoluble mucins, which were solubilized with 10 mM dithiothreitol (DTT) in reduction buffer (6 M GuHCl,
5 mM EDTA, 0.1 M Tris-HCl, pH 8) for 5 h at 37°C. Finally, residues were alkylated overnight with 25 mM
iodoacetamide (IAA; Alfa Aesar, Karlsruhe, Germany).
Both the GuHCl-soluble and -insoluble material was dialyzed in 10 volumes of extraction buffer at
4°C, with the dialysis solution being changed three times in 24 h. An isopycnic density gradient
centrifugation in cesium chloride (CsCl)–4 M GuHCl with a starting density of 1.39 g/ml was performed
at 40,000 rpm for 90 h. The mucin-containing fractions were pooled and further puriﬁed from DNA by a
second gradient in CsCl–0.5 M GuHCl. Approximately 25 mucin fractions were recovered per sample
using a fraction collector equipped with a drop counter. The fractions were stored at 4°C until further
analysis.
Analysis of mucin fractions. The ﬁrst and second CsCl gradient mucin fractions were analyzed as
previously described (2). A microtiter-based assay detecting carbohydrates as periodate-oxidizable
structures (20) was performed in order to determine the glycan content in the GuHCl-soluble and
-insoluble mucin samples. Brieﬂy, Nunc 96-well plates (Thermo Scientiﬁc, Waltham, MA, USA) were
coated overnight at 4°C with mucin fractions diluted in 4 M and 0.5 M GuHCl. The plates were incubated
with a 25 mM sodium metaperiodate solution diluted in sodium acetate (NaAc) for 20 min and blocked
with 50 mM Tris-HCl, 0.15 M NaCl, 90 M CaCl2, 4 M EDTA, 0.01% NaN3, and 2% bovine serum albumin
at pH 8 for 1 h. The wells were then incubated for 1 h with a biotin hydrazide solution diluted 1/50 in
NaAc, followed by europium-labeled streptavidin diluted 1/1,000 in DELFIA assay buffer (PerkinElmer,
Waltham, MA, USA). Finally, the plates were incubated with DELFIA enhancement solution for 5 min on
a shaker. Between each step the plates were washed three times with a solution containing 5 mM
Tris-HCl, 0.15 M NaCl, 0.005% Tween 20, and 0.01% NaN3 at pH 7.75, except for the ﬁnal step, where the
plates were washed six times. The signal was measured in a Wallac 1420 Victor2 microplate reader
(PerkinElmer, Waltham, MA, USA) by time-resolved ﬂuorometry.
Mucin sample preparation and concentration estimation. Mucin sample preparation and con-
centration estimation were performed as previously described (2). Brieﬂy, gradient fractions containing
mucins were pooled to obtain one sample for each gradient. Liquid chromatography-tandem mass
spectrometry spectra (8) were analyzed for the presence of carbohydrates of bacterial origin, which were
not observed in any mucin samples. Mucin concentrations in pooled samples were determined by the
use of serial dilutions as well as a standard curve of a fusion protein of the mucin MUC1, 16TR (tandem
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repeat), and IgG2a Fc (51), starting at a concentration of 20 mg/ml and using seven 1/2 serial dilutions
in the carbohydrate detection assay described above. The mucin concentrations were calculated from
the standard curve. Setting the concentration based on the glycan content appears to be the most
appropriate, as bacterium-mucin interactions largely occur via the mucin glycans (1). Although this is not
an absolute measure of the concentration, it can be used to ensure that the mucins are at the same
concentration for comparative assays.
B. hyodysenteriae strain. B. hyodysenteriae strain 8dII, isolated from a farm with pigs with muco-
hemorrhagic diarrhea, was cultured on tryptone soy agar (Thermo Fisher Scientiﬁc, Waltham, MA, USA)
plates supplemented with 5% sheep blood (Thermo Fisher Scientiﬁc, Waltham, MA, USA), 0.1% yeast
extract (Merck, Darmstadt, Germany), and 400 g/ml spectinomycin, 25 g/ml colistin, and 25 g/ml
vancomycin (AppliChem, Darmstadt, Germany) at 40°C under anaerobic conditions.
B. hyodysenteriae adhesion to enzyme-treated mucins. The roles of sialic acid and galactose in B.
hyodysenteriae adhesion were analyzed after sialidase A and -galactosidase treatment of pig colon
insoluble mucins isolated as previously described (2). White 96-well plates (Corning Life Sciences,
Corning, NY, USA) were coated at 4°C for 12 h with 100 l pig colonic mucins at 6 g/ml in 0.5 M GuHCl.
The wells were washed three times with PBS with Tween 20 (PBS-T) and blocked with 200 l of 5% fetal
bovine serum (FBS) for 1 h. For enzyme treatment of mucins, 75 l of sialidase A (1 U/200 l; Prozyme,
CA, USA) diluted 1:200 and (1-4)-galactosidase (0.5 U/100 l; Prozyme, CA, USA) diluted 1:50 in 50 mM
Na3PO4, pH 6.0, were added per well, and the plates were incubated for 11 h at 37°C.
Subsequently, the wells were washed with PBS-T and blocked with 200 l of 5% FBS for 1 h. Bacteria
were harvested from tryptic soy agar plates, washed in PBS, centrifuged at 2,500 g for 5 min, and
resuspended in PBS containing 5% FBS. One hundred microliters of a bacterial suspension diluted to 108
bacterial cells/ml was added per well, and the plates were shaken during incubation for 2 h at 40°C in
an anaerobic environment. The plates were washed three times with PBS-T and once with PBS.
Subsequently, 100 l of PBS was added to each well, followed by the addition of an equal volume of
BacTiter-Glo reagent (Promega, Madison, WI, USA). Incubation proceeded for 5 min at room temperature.
The BacTiter-Glo microbial cell viability method results in a luminescent signal proportional to the
amount of ATP present, which in turn is proportional to the number of viable bacterial cells in the culture.
Relative luminescence (RLU) was measured in an Inﬁnite M200 microplate reader (Tecan, Männedorf,
Switzerland) with an integration time of 1,000 ms per well. Controls included mucin-coated wells with
enzyme, mucin-coated wells without enzyme (50 mM Na3PO4, pH 6.0), non-mucin-coated wells (0.5 M
GuHCl) with enzyme, and non-mucin-coated wells without enzyme (50 mM Na3PO4, pH 6.0) incubated
with bacteria, followed by addition of PBS and reagent. Results were obtained from three independent
experiments with six technical replicates and were plotted as relative luminescence (RLU).
B. hyodysenteriae growth in the presence of mucins and monosaccharides. Bacterial growth in
the presence of mucins was performed as previously described (52). Mucins were dialyzed against four
changes of 2 M NaCl, followed by two changes against sterile PBS. Twenty-ﬁve microliters of colonic
mucins from ﬁve B. hyodysenteriae-infected pigs and six healthy pigs (2) and the carbohydrates galactose,
fucose, NeuAc, NeuGc, GlcNAc, and GalNAc (Sigma-Aldrich, St. Louis, MO, USA) diluted in PBS (100 g/ml)
were added to a sterile Falcon 96-well plate (Corning Life Sciences, Corning, NY, USA). B. hyodysenteriae
was harvested from the agar plates, washed in PBS, and resuspended in carbohydrate-free medium (40)
to an optical density at 600 nm (OD600) of 0.1. RealTime-Glo cell viability assay reagent (Promega,
Madison, WI, USA) was diluted 1/1,000 in the bacterial suspension, and 225 l of the bacterial suspension
with the reagent was added per well. The microtiter plate was covered with a sterile gas-permeable
sealing membrane (Diversiﬁed Biotech, Dedham, MA, USA) and incubated at 40°C inside a plate reader
(CLARIOstar; BGM Labtech GmbH, Ortenberg, Germany) connected to an atmospheric unit set to 0.1% O2.
Luminescence readings were measured every 2 h for 24 h. Proliferation control wells contained PBS
instead of mucins or monosaccharides, in addition to the bacterial suspension and reagent. To ensure
that the residual CsCl and GuHCl in the pig colonic mucins had no adverse effects on B. hyodysenteriae
growth, a control consisting of CsCl dissolved in 0.5 M GuHCl was dialyzed in parallel to the mucins, with
the results on B. hyodysenteriae growth being similar to those for the PBS control.
Fluorometric assay of B. hyodysenteriae neuraminidase. Eighty microliters of 2=-(4-methylumbelliferyl)-
-D-N-acetylneuraminic acid sodium salt hydrate substrate (500 M; catalog number 69587; Sigma) and
20 l of a B. hyodysenteriae suspension in deﬁned medium (OD600, 0.1) were added to a Falcon 96-well
plate. Sialidase A (5 U/ml; ProZyme; Hayward, Canada) diluted 1,000-fold in a 100-l ﬁnal volume
was added along with substrate as a positive control, while deﬁned medium and substrate were used
as a negative control. Sialidase activity was measured by analyzing the ﬂuorescence of liberated
4-methylumbelliferyl from the 2=-(4-methylumbelliferyl)--D-N-acetylneuraminic acid sodium salt hydrate
substrate as relative ﬂuorescence units (RFU) at an excitation wavelength of 340 nm and an emission
wavelength of 420 nm in a plate reader (BMG Labtech, Ortenberg, Germany) every 10 min for 11 h.
Statistical analysis. Statistical analysis was performed using GraphPad Prism (version 6) software
(GraphPad Software, La Jolla, CA, USA). Results are expressed as the mean  standard error of the mean
(SEM) for normally distributed data (determined by the D’Agostino-Pearson omnibus test). Equality of
variances between groups was assessed by Barlett’s test. Data were analyzed using one-way analysis of
variance (ANOVA), and P values of 0.05 were considered statistically signiﬁcant. The Pearson product-
moment correlation coefﬁcient (r) was computed to assess the relationship between two variables.
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